1[1]Keiskanen-Kosma T,Korppi M,Jokinen C,et al.Etiology of childhood pneumonia: serologic results of a prospective,population-based study[J].Pediatr Infect Dis,1998,17(11):986-991.
2[2]SuCJ,Dallo SF,Baseman JB,et al.Possible origin of sequence divergence in the P1 cytadhesin gene of mycoplasma pneumoniae[J].Infect Immun,1993,61:816-822.
3[3]Cole BC.Mycoplasma interactions with the immune system:implications for disease pathology[J].ASM News,1996,62:471-475.
4[4]TanaKa H,Koba H,Honma S,et al.Relationships between radiological pattern and cell-mediated immune response in mycoplasma pneumoniae pneumonia[J].Eur Respir,1996 ,9(4):669-672.
5[5]Romero Rojas A,Ponce Hernandez C,Ciprian A,et al.Immunomodulatory properties of mycoplasma pulmonisⅠcharacterization of the immunomodulatory activity[J].Int Immunopharmacol,2001 ,1(9-10):1679-1688.
6[6]Tanaka H,Abe S,Tamura H.Pathological changes by the imbalance of host T helper lymphocyte subsets in mycoplasma pulmonis pneumonia of mice[J].Kansenshogaku Zasshi,1998 ,72(4):342-346.
7[7]Koh YY,Park Y,Lee HJ,et al.Levels of IL-2,IFN-r,IL-4 in BLF From patients with mycoplasma pneumonia[J].Pediatrics,2001 ,107(3):E39.
8[8]Romero-Rojas A,Ponce-Hernandez C,Mendoza SE,et al.Immunomodulatory properties of mycoplasma pulmonis Ⅱstudies on the mechanisms of immunomodulation[J].Int Immunopharmacol,2001 ,1(9-10):1689-1697.
9[9]Walker J,Lee R,Mathy N,et al.Restricted B-cell responese to microbial challenge of the respiratroy tract[J].Vet Immunol Immunopathol,1996,54(1-4):197-204.
10[10]Baseman JB,Reddy SP,Pallo SF.Interplay between mycoplasma surface proteins,airway cells,and the protean manifestations of mycoplasma-mediated human infections[J].Am J Respir Crit Care Med,1996 ,154(4):s137-144.
